Vogt Koyanagi Harada Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Vogt Koyanagi Harada Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT03399175

Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immu…

Brazil40 participantsStarted 2015-03-23

Treatment: Early high-dose corticosteroid and immunosuppressive therapy

RecruitingNot Applicable

NCT05590416

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

This project is designed to test the hypothesis that adalimumab is clinically useful for patients with acuta Vogt-Koyanagi-Harada disease

China15 participantsStarted 2021-06-01

Treatment: Adalimumab

All recent trials (13 shown)

CompletedNot Applicable

NCT07405489

Oral Prednisolone Versus Posterior Sub-Tenon Triamcinolone for Acute Ocular VKH

Vogt-Koyanagi-Harada (VKH) disease is a rare autoimmune disorder characterized by bilateral ocular inflammation that may lead to serous retinal detachment and p…

Egypt30 participantsStarted 2021-01-01

WithdrawnPhase 3

NCT00407121

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizuma…

Mexico0Started 2006-12

Treatment: Bevacizumab, Intravitreal Injection of Bevacizumab

UnknownNot Applicable

NCT05627739

Vogt Koyanagi Harada Disease

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

All recent trials (13 shown)

Oral Prednisolone Versus Posterior Sub-Tenon Triamcinolone for Acute Ocular VKH

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

All recent trials (13 shown)

Oral Prednisolone Versus Posterior Sub-Tenon Triamcinolone for Acute Ocular VKH

Intravitreal Bevacizumab for Inflammatory Neovascular Membranes

A Study of Mycophenolate Mofetil Combined With Glucocorticoid Therapy in Relapse Vogt-Koyanagi-Harada Disease

Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)

Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada Disease

Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

Corticosteroid Combining Noncorticosteroid Systemic Immunomodulatory Therapy in VKH

Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

Dexamethasone Intravitreal Implant (Ozurdex®) for Recurrent Vogt-Koyanagi-Harada (VKH) Disease Posterior Uveitis

Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uvei…

Safety and Efficacy of AIN457 in Noninfectious Uveitis